Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Hepatol. Dec 28, 2017; 9(36): 1322-1331
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1322
Table 3 Multivariate Cox regression model including alphafetoprotein and disease control as time dependent covariates
VariableMultivariate analysis
Hazard ratio (95%CI)P value
Macrovascular invasion
No10.917
Yes1.066 (0.412-2.762)
Macrovascular invasion and/or extrahepatic spread
No10.366
Yes1.552 (0.584-4.124)
Tumor size
≤ 5 cm10.266
> 5 cm1.369 (0.786-2.382)
AFP (> 200 ng/mL vs ≤ 200 ng/mL)
< 6 mo5.073 (2.159-11.916)0.00021
7-12 mo0.948 (0.275-3.267)0.932
> 12 mo1.698 (0.620-4.648)0.303
DC (Yes vs No)
< 6 mo0.220 (0.075-0.650)0.096
7-12 mo0.463 (0.181-1.189)0.109
> 12 mo0.110 (0.038-0.314)< 0.00011

  • Citation: Ponziani FR, Spinelli I, Rinninella E, Cerrito L, Saviano A, Avolio AW, Basso M, Miele L, Riccardi L, Zocco MA, Annicchiarico BE, Garcovich M, Biolato M, Marrone G, De Gaetano AM, Iezzi R, Giuliante F, Vecchio FM, Agnes S, Addolorato G, Siciliano M, Rapaccini GL, Grieco A, Gasbarrini A, Pompili M. Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1322-1331
  • URL: https://www.wjgnet.com/1948-5182/full/v9/i36/1322.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v9.i36.1322